BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25869099)

  • 21. Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kδ or PKCβ signaling pathways.
    Amigo-Jiménez I; Bailón E; Aguilera-Montilla N; Terol MJ; García-Marco JA; García-Pardo A
    Oncotarget; 2015 Dec; 6(42):44832-48. PubMed ID: 26540567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of exosomes derived from B-cell acute lymphoblastic leukemia as a growth factor on bone marrow mesenchymal stromal cells.
    Amirpour M; Kuhestani-Dehaghi B; Kheyrandish S; Hajipirloo LK; Khaffafpour Z; Keshavarz F; Allahbakhshian-Farsani M
    Mol Biol Rep; 2024 Jun; 51(1):749. PubMed ID: 38874800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel xenograft model to study the role of TSLP-induced CRLF2 signals in normal and malignant human B lymphopoiesis.
    Francis OL; Milford TA; Martinez SR; Baez I; Coats JS; Mayagoitia K; Concepcion KR; Ginelli E; Beldiman C; Benitez A; Weldon AJ; Arogyaswamy K; Shiraz P; Fisher R; Morris CL; Zhang XB; Filippov V; Van Handel B; Ge Z; Song C; Dovat S; Su RJ; Payne KJ
    Haematologica; 2016 Apr; 101(4):417-26. PubMed ID: 26611474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-DNA-binding Ikaros isoform gene expressed in adult B-precursor acute lymphoblastic leukemia.
    Nishii K; Katayama N; Miwa H; Shikami M; Usui E; Masuya M; Araki H; Lorenzo F; Ogawa T; Kyo T; Nasu K; Shiku H; Kita K
    Leukemia; 2002 Jul; 16(7):1285-92. PubMed ID: 12094252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HoxA9 induces insulin-like growth factor-1 receptor expression in B-lineage acute lymphoblastic leukemia.
    Whelan JT; Ludwig DL; Bertrand FE
    Leukemia; 2008 Jun; 22(6):1161-9. PubMed ID: 18337761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stromal cell-mediated transcriptional regulation of the CD13/aminopeptidase N gene in leukemic cells.
    Saito M; Kumagai M; Okazaki T; Nakazawa S; Shapiro LH; Look AT; Campana D
    Leukemia; 1995 Sep; 9(9):1508-16. PubMed ID: 7658720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Galectin 3 as a guardian of the tumor microenvironment.
    Ruvolo PP
    Biochim Biophys Acta; 2016 Mar; 1863(3):427-437. PubMed ID: 26264495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A childhood acute lymphoblastic leukemia-specific lncRNA implicated in prednisolone resistance, cell proliferation, and migration.
    Ouimet M; Drouin S; Lajoie M; Caron M; St-Onge P; Gioia R; Richer C; Sinnett D
    Oncotarget; 2017 Jan; 8(5):7477-7488. PubMed ID: 27980230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A functional receptor for B-cell-activating factor is expressed on human acute lymphoblastic leukemias.
    Parameswaran R; Müschen M; Kim YM; Groffen J; Heisterkamp N
    Cancer Res; 2010 Jun; 70(11):4346-56. PubMed ID: 20460528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a model for evaluating the interaction between human pre-B acute lymphoblastic leukemic cells and the bone marrow stromal cell microenvironment.
    Shah N; Oseth L; LeBien TW
    Blood; 1998 Nov; 92(10):3817-28. PubMed ID: 9808575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term survival and proliferation of precursor-B acute lymphoblastic leukemia cells on human bone marrow stroma.
    Bradstock K; Bianchi A; Makrynikola V; Filshie R; Gottlieb D
    Leukemia; 1996 May; 10(5):813-20. PubMed ID: 8656676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p21(WAF1) modulates drug-induced apoptosis and cell cycle arrest in B-cell precursor acute lymphoblastic leukemia.
    Davies C; Hogarth LA; Mackenzie KL; Hall AG; Lock RB
    Cell Cycle; 2015; 14(22):3602-12. PubMed ID: 26506264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Selective Galectin-3 Antagonists Are Cytotoxic to Acute Lymphoblastic Leukemia.
    Bum-Erdene K; Collins PM; Hugo MW; Tarighat SS; Fei F; Kishor C; Leffler H; Nilsson UJ; Groffen J; Grice ID; Heisterkamp N; Blanchard H
    J Med Chem; 2022 Apr; 65(8):5975-5989. PubMed ID: 35427125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy.
    Hsieh YT; Gang EJ; Geng H; Park E; Huantes S; Chudziak D; Dauber K; Schaefer P; Scharman C; Shimada H; Shojaee S; Klemm L; Parameswaran R; Loh M; Kang ES; Koo HH; Hofmann WK; Andrade J; Crooks GM; Willman CL; Müschen M; Papayannopoulou T; Heisterkamp N; Bönig H; Kim YM
    Blood; 2013 Mar; 121(10):1814-8. PubMed ID: 23319569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of acute lymphoblastic leukemia with an rGel/BLyS fusion toxin.
    Parameswaran R; Yu M; Lyu MA; Lim M; Rosenblum MG; Groffen J; Heisterkamp N
    Leukemia; 2012 Aug; 26(8):1786-96. PubMed ID: 22373785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of galectin-3 up-regulates IgA expression by peritoneal B1 lymphocytes during B cell differentiation.
    Oliveira FL; Bernardes ES; Brand C; dos Santos SN; Cabanel MP; Arcanjo KD; Brito JM; Borojevic R; Chammas R; El-Cheikh MC
    Cell Tissue Res; 2016 Feb; 363(2):411-26. PubMed ID: 26003178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Galectins as regulators of cell survival in the leukemia niche.
    Ruvolo PP
    Adv Biol Regul; 2019 Jan; 71():41-54. PubMed ID: 30245264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Migration of acute lymphoblastic leukemia cells into human bone marrow stroma.
    Makrynikola V; Bianchi A; Bradstock K; Gottlieb D; Hewson J
    Leukemia; 1994 Oct; 8(10):1734-43. PubMed ID: 7523799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stromal cell-mediated mitochondrial redox adaptation regulates drug resistance in childhood acute lymphoblastic leukemia.
    Liu J; Masurekar A; Johnson S; Chakraborty S; Griffiths J; Smith D; Alexander S; Dempsey C; Parker C; Harrison S; Li Y; Miller C; Di Y; Ghosh Z; Krishnan S; Saha V
    Oncotarget; 2015 Dec; 6(40):43048-64. PubMed ID: 26474278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of galectin-3 increases Jagged1/Notch activation in bone marrow-derived dendritic cells and promotes dysregulation of T helper cell polarization.
    Fermino ML; Dylon LS; Cecílio NT; Santos SN; Toscano MA; Dias-Baruffi M; Roque-Barreira MC; Rabinovich GA; Bernardes ES
    Mol Immunol; 2016 Aug; 76():22-34. PubMed ID: 27344022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.